Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees Hendricksen

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
The American Journal of Surgical Pathology|September 17, 2019
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder CarcinomaCharlotte S Voskuilen, Htoo Zarni Oo, Vera Genitsch, et al.
Urologic Oncology|June 9, 2018
Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancerElisabeth E Fransen van de Putte, Wolfgang Otto, Arndt Hartmann, et al.
International Journal of Cancer|October 2, 2020
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladderThomas van Doeveren, Jose A Nakauma-Gonzalez, Andrew S Mason, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.
Journal of Clinical Medicine|October 20, 2020
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic BenefitWojciech Krajewski, Marco Moschini, Łukasz Nowak, et al.
World Journal of Urology|November 24, 2020
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomesWojciech Krajewski, Marco Moschini, Joanna Chorbińska, et al.
Urologic Oncology|September 28, 2021
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohortSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
Minerva Urology and Nephrology|February 20, 2023
Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registryJulien Sarkis, Romain Diamand, Fouad Aoun, et al.
Journal of Endourology|February 3, 2022
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication IndexSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The American Journal of Surgical Pathology|September 17, 2019
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder CarcinomaCharlotte S Voskuilen, Htoo Zarni Oo, Vera Genitsch, et al.
Urologic Oncology|June 9, 2018
Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancerElisabeth E Fransen van de Putte, Wolfgang Otto, Arndt Hartmann, et al.
International Journal of Cancer|October 2, 2020
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladderThomas van Doeveren, Jose A Nakauma-Gonzalez, Andrew S Mason, et al.
World Journal of Urology|February 10, 2022
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.
Journal of Clinical Medicine|October 20, 2020
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic BenefitWojciech Krajewski, Marco Moschini, Łukasz Nowak, et al.
World Journal of Urology|November 24, 2020
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomesWojciech Krajewski, Marco Moschini, Joanna Chorbińska, et al.
Urologic Oncology|September 28, 2021
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohortSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
Minerva Urology and Nephrology|February 20, 2023
Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registryJulien Sarkis, Romain Diamand, Fouad Aoun, et al.
Journal of Endourology|February 3, 2022
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication IndexSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
Pageof 10